Back
Lyell Immunopharma Vs. Eliem Therapeutics Industry Stock Comparison
Buy
59
LYEL
Lyell Immunopharma
Last Price:
2.74
Seasonality Move:
37.44%
Sell
45
ELYM
Eliem Therapeutics
Last Price:
8.17
Seasonality Move:
-25.18%
Buy
59
Lyell Immunopharma (LYEL)
is a Buy
Is Lyell Immunopharma a Buy, Sell or Hold?
- The current Lyell Immunopharma [LYEL] share price is $2.74. The Score for LYEL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Eliem Therapeutics (ELYM)
is a Sell
Is Eliem Therapeutics a Buy, Sell or Hold?
- The current Eliem Therapeutics [ELYM] share price is $8.25. The Score for ELYM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- ELYM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LYEL Stock Price Chart
What is Lyell Immunopharma's stock price today?
-
The Lyell Immunopharma share price today is $2.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
ELYM Stock Price Chart
What is Eliem Therapeutics's stock price today?
-
The Eliem Therapeutics share price today is $8.25
The current trend is moderately bullish and ELYM is experiencing slight buying pressure.
LYEL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 60.07 | Buy |
Chaikin Money Flow: | -575819 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.26 - 2.58) | Buy |
Bollinger Bands (100): | (1.93 - 2.53) | Buy |
ELYM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.17 | Buy |
Relative Strength Index (14 RSI): | 61.35 | Buy |
Chaikin Money Flow: | 47362 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.31 - 8.93) | Buy |
Bollinger Bands (100): | (1.71 - 5.79) | Buy |
LYEL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.59 | Buy |
20-day SMA: | 2.44 | Buy |
50-day SMA: | 2.32 | Buy |
200-day SMA: | 2.06 | Buy |
8-day EMA: | 2.61 | Buy |
20-day EMA: | 2.49 | Buy |
50-day EMA: | 2.37 | Buy |
200-day EMA: | 2.36 | Buy |
ELYM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.47 | Sell |
20-day SMA: | 7.18 | Buy |
50-day SMA: | 4.75 | Buy |
200-day SMA: | 3.18 | Buy |
8-day EMA: | 8.27 | Sell |
20-day EMA: | 7.35 | Buy |
50-day EMA: | 5.56 | Buy |
200-day EMA: | 3.73 | Buy |
Lyell Immunopharma Earnings Growth & LYEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.04 per share.
Eliem Therapeutics Earnings Growth & ELYM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lyell Immunopharma Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eliem Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |